John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Vera Bradley
VRA
$88.2M
| $1.59M | ﹤0.01% |
206,752
+26,110
| +14% | +$206K |
|
1452
Immersion
IMMR
$250M
| $1.58M | ﹤0.01% |
283,880
-89,967
| -24% | -$466K |
|
|
CANO
1453
DELISTED
Cano Health, Inc.
CANO
| $1.58M | ﹤0.01% |
2,482
-3,464
| -58% | -$2.18M |
|
1454
FB Financial Corp
FBK
$2.88B
| $1.57M | ﹤0.01% |
35,379
+260
| +0.7% | +$11.6K |
|
|
CSTR
1455
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.57M | ﹤0.01% |
74,373
+14,871
| +25% | +$318K |
|
1456
Piper Sandler
PIPR
$5.26B
| $1.56M | ﹤0.01% |
+47,700
| New | +$1.76M |
|
1457
Travelers Companies
TRV
$76.5B
| $1.56M | ﹤0.01% |
8,516
-11,004
| -56% | -$1.89M |
|
|
WBA
1458
DELISTED
Walgreens Boots Alliance
WBA
| $1.54M | ﹤0.01% |
+34,443
| New | +$1.69M |
|
1459
BlackSky Technology
BKSY
$1.03B
| $1.53M | ﹤0.01% |
101,550
+84,942
| +511% | +$1.78M |
|
1460
Broadstone Net Lease
BNL
$4.39B
| $1.53M | ﹤0.01% |
+70,498
| New | +$1.57M |
|
1461
Moog Inc Class A
MOG.A
$12B
| $1.53M | ﹤0.01% |
17,484
+145
| +0.8% | +$11.8K |
|
1462
Clean Energy Fuels
CLNE
$351M
| $1.53M | ﹤0.01% |
193,216
-112,484
| -37% | -$758K |
|
1463
Independent Bank Corp
IBCP
$816M
| $1.53M | ﹤0.01% |
69,430
+706
| +1% | +$17K |
|
1464
Aldeyra Therapeutics
ALDX
$91.1M
| $1.52M | ﹤0.01% |
342,887
-334,185
| -49% | -$1.33M |
|
1465
Information Services Group
III
$240M
| $1.52M | ﹤0.01% |
223,392
-106,817
| -32% | -$753K |
|
1466
Verastem
VSTM
$638M
| $1.52M | ﹤0.01% |
89,780
-11,823
| -12% | -$204K |
|
1467
Monarch Casino & Resort
MCRI
$2.21B
| $1.51M | ﹤0.01% |
+17,357
| New | +$1.3M |
|
1468
Gladstone Investment Corp
GAIN
$656M
| $1.51M | ﹤0.01% |
93,755
-37,354
| -28% | -$587K |
|
|
AGEN
1469
Agenus
AGEN
$371M
| $1.51M | ﹤0.01% |
31,290
-4,941
| -14% | -$267K |
|
1470
Tenaris
TS
$27.5B
| $1.51M | ﹤0.01% |
+50,091
| New | +$1.3M |
|
1471
Remitly
RELY
$5.54B
| $1.5M | ﹤0.01% |
+152,483
| New | +$1.82M |
|
1472
Renasant Corp
RNST
$3.75B
| $1.5M | ﹤0.01% |
45,007
+22,159
| +97% | +$812K |
|
|
NEUE
1473
DELISTED
NeueHealth
NEUE
| $1.5M | ﹤0.01% |
9,734
+2,416
| +33% | +$537K |
|
|
NVMI
1474
Nova
NVMI
$11.7B
| $1.5M | ﹤0.01% |
13,736
-29,332
| -68% | -$3.43M |
|
|
PINE
1475
Alpine Income Property Trust
PINE
$346M
| $1.5M | ﹤0.01% |
79,576
-13,763
| -15% | -$265K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.